These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28894562)

  • 1. Clinical Course and Prognosis of Non-Secretory Multiple Myeloma.
    Chawla SS; Kumar SK; Dispenzieri A; Greenberg AJ; Larson DR; Kyle RA; Lacy MQ; Gertz MA; Rajkumar SV
    Eur J Haematol; 2015 Feb; ():. PubMed ID: 25690913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Secretory Multiple Myeloma: A New Observation and Review of the Literature.
    Ouzzif Z; Eddair Y; Laassara W; El Maaroufi H; Mahtat EM
    Cureus; 2024 Feb; 16(2):e54479. PubMed ID: 38510859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma.
    Agulló C; Puig N; Contreras T; Castro S; Puertas B; González-Calle V; Rey-Búa B; Mateos MV
    Biomedicines; 2024 May; 12(6):. PubMed ID: 38927360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum free light chains and multiple myeloma: Is it time to extend their application?
    Markovic U; Leotta V; Tibullo D; Giubbolini R; Romano A; Del Fabro V; Parrinello NL; Cannizzaro MT; Di Raimondo F; Conticello C
    Clin Case Rep; 2020 Apr; 8(4):617-624. PubMed ID: 32274022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.
    Visram A; Rajkumar SV; Kapoor P; Dispenzieri A; Lacy MQ; Gertz MA; Buadi FK; Hayman SR; Dingli D; Kourelis T; Gonsalves W; Warsame R; Muchtar E; Leung N; Kyle RA; Kumar SK
    Leukemia; 2024 Aug; 38(8):1862. PubMed ID: 38956316
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients.
    Blancas-Mejía LM; Martin EB; Williams A; Wall JS; Ramirez-Alvarado M
    Biophys Chem; 2017 Nov; 230():89-98. PubMed ID: 28916410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma.
    Migkou M; Avivi I; Gavriatopoulou M; Cohen YC; Fotiou D; Kanellias N; Ziogas D; Eleutherakis-Papaiakovou E; Terpos E; Roussou M; Kastritis E; Dimopoulos MA
    Ann Hematol; 2020 Jun; 99(6):1251-1255. PubMed ID: 32307566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated Non-Secretory Extramedullary Relapse of Multiple Myeloma Responded Completely to Localized Radiotherapy.
    Dawd D; Kapur S; Kotchetkov R
    Case Rep Oncol; 2024; 17(1):423-429. PubMed ID: 38444889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of multiple myeloma: A monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities.
    Abduh MS
    Saudi J Biol Sci; 2024 Feb; 31(2):103920. PubMed ID: 38283805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photon Counting Detector Computed Tomography: A New Frontier of Myeloma Bone Disease Evaluation.
    Cook J; Rajendran K; Ferrero A; Dhillon P; Kumar S; Baffour F
    Acta Haematol; 2023; 146(5):419-423. PubMed ID: 37339614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report.
    Verma K; Zhang T; Mueller D; Li J; Sanchorawala V; Staron A
    Diagn Pathol; 2023 Jan; 18(1):1. PubMed ID: 36597112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Analysis of M-protein in Plasma cell Dyscrasia Patients Identifies that IgG Lambda Subtype is More Commonly Associated with Normal Serum Free Light Chain (SFLC) Ratio.
    Singh MK; Paswan V; Dwivedi S; Gupta R; Rahman K; Chandra D; Yadav S; Gupta A; Kashyap R; Nityanand S
    Indian J Clin Biochem; 2022 Oct; 37(4):466-472. PubMed ID: 36262785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-secretory multiple myeloma expressed as multiple extramedullary plasmacytoma with an endobronchial lesion mimicking metastatic cancer: A case report.
    Lee SB; Park CY; Lee HJ; Hong R; Kim WS; Park SG
    World J Clin Cases; 2022 Aug; 10(22):7899-7905. PubMed ID: 36158506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of natural killer cell recovery on minimal residual disease after autologous stem cell transplantation in multiple myeloma.
    Keruakous AR; Asch A; Aljumaily R; Zhao D; Yuen C
    Transpl Immunol; 2022 Apr; 71():101544. PubMed ID: 35093506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsecretory Multiple Myeloma Presenting as Recurrent Vertebral Compression Fractures in an Older Male Patient.
    Maeng YH; Hyun CL; Han SH; Seong GM; Song DH; An HJ; Koh HM
    Ann Geriatr Med Res; 2018 Jun; 22(2):98-101. PubMed ID: 32743254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare case of non-producer variant of plasma cell dyscrasias with circulating plasma cells.
    Manthri S; Zafar R; Cornell RF; Chakraborty K
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31767606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Secretory Myeloma: Ready for a new Definition?
    Corso A; Mangiacavalli S
    Mediterr J Hematol Infect Dis; 2017; 9(1):e2017053. PubMed ID: 28894562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Case of Non-Secretory Multiple Myeloma: A Case Report and Literature Review.
    Bensalah M; Lamrabat S; Lyagoubi A; Aarab A; Bouayadi O; Seddik R
    EJIFCC; 2019 Mar; 30(1):88-94. PubMed ID: 30881278
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.